ADVFN US – Market Content Editor
-

AMC CEO Adam Aron suffers minor stroke but remains fully active in his leadership role
AMC Entertainment Holdings (NYSE:AMC) announced that Chairman and CEO Adam Aron, 71, experienced a minor stroke on November 17 while traveling for business in London, though he has continued to carry out his duties and remains fully engaged in running the company. Aron received emergency treatment at the National Hospital for Neurology and Neurological Sciences,…
-

Hormel Foods climbs 4% as upbeat fiscal 2026 outlook offsets softer Q4 results
Hormel Foods Corporation (NYSE:HRL) reported fourth-quarter results on Thursday that met expectations but were weighed down by sizable impairment charges. Still, shares rose 4% in pre-market trading as investors focused on the company’s stronger-than-expected fiscal 2026 guidance. The producer of Spam, Skippy, and Planters posted adjusted earnings of $0.32 per share, matching consensus estimates. Revenue…
-

Amazon said to be preparing to phase out USPS partnership as it expands delivery network
Amazon (NASDAQ:AMZN) is reportedly preparing to broaden its U.S. delivery infrastructure and unwind its long-running partnership with the U.S. Postal Service, according to a report from The Washington Post on Thursday. The newspaper, citing three individuals familiar with the discussions, said the e-commerce giant is moving toward handling a larger share of its own last-mile…
-

Genesco shares sink 12% as weak Schuh performance forces sharp guidance cut
Genesco Inc. (NYSE:GCO) saw its stock tumble 12.06% in pre-market trading on Thursday after the footwear retailer slashed its full-year outlook, overshadowing a third-quarter report that otherwise showed continued momentum in comparable sales. For the quarter, Genesco posted adjusted earnings of $0.79 per share on revenue of $616 million—missing analyst expectations of $0.88 per share…
-

Hapag-Lloyd reportedly submits offer for ZIM Integrated Shipping; shares climb 4%
Shares of ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) rose 4% on Thursday after Globes reported that German shipping heavyweight Hapag-Lloyd (TG:HLAG) has made a preliminary acquisition bid for the company. According to the report, the offer remains at an early stage, and formal negotiations have not yet begun. ZIM—currently the world’s ninth-largest container carrier with…
-

America’s Car-Mart rises 2% premarket as investors look past earnings miss and focus on capital overhaul
America’s Car-Mart (NASDAQ:CRMT) reported a wider-than-expected loss for its fiscal second quarter on Thursday, but shares still gained 2.06% in pre-market trading as investors emphasized the company’s ongoing capital restructuring efforts and improvements in its credit portfolio. The used car retailer posted an adjusted loss of $0.79 per share, sharply missing analyst expectations for a…
-

Wiley shares slip as Q2 revenue misses forecasts despite earnings outperformance
Wiley (NYSE:WLY) reported mixed second-quarter results on Thursday, beating profit expectations but falling short on revenue, which pushed its shares down 2.35% in pre-market trading. For the quarter ended October 31, the research and education publisher posted adjusted earnings per share of $1.10, topping the consensus estimate of $1.00. Revenue, however, totaled $422 million —…
-

Ekso Bionics jumps 20% after securing exclusive U.S. distribution rights for BalanceTutor system
Shares of Ekso Bionics Holdings Inc. (NASDAQ:EKSO) soared 20% on Thursday after the company announced a new agreement that makes it the exclusive U.S. distributor for MediTouch’s BalanceTutor rehabilitation system. Ekso Bionics — known for its medical and industrial exoskeleton technologies — will act as the authorized sales agent for the advanced balance-retraining solution across…
-

Rex American Resources posts strong Q3 beat as ethanol output remains robust
Rex American Resources Corp. (NYSE:REX) reported fiscal third-quarter 2025 results on Thursday that surpassed Wall Street expectations, delivering adjusted earnings per share of $0.71 — far above the consensus estimate of $0.27. Revenue came in at $175.6 million, also ahead of the projected $169 million. Shares of the ethanol producer rose 1.55% in pre-market trading…
-

Crescent Biopharma jumps 12% after unveiling Kelun-Biotech collaboration and $185 million financing
Crescent Biopharma (NASDAQ:CBIO) surged 12% on Thursday after announcing a new strategic alliance with Kelun-Biotech alongside a $185 million private placement aimed at accelerating its cancer drug pipeline. Under the partnership, Kelun-Biotech receives exclusive rights to develop Crescent’s PD-1 x VEGF bispecific antibody (CR-001) in Greater China. In return, Crescent gains exclusive access to Kelun-Biotech’s…